| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |